Evaluation of the Efficacy of Biologics for Asthma in the Real World

Evaluation of the Efficacy of Biological Agents for Bronchial Asthma in the Real World and Exploration of Biomarkers for Predicting Efficacy: A Prospective Registry Study. Registry name: Dynamic Evaluation in Real-World Biological Therapy for Severe Asthma (DERBY)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1031230202

Enrollment

200

Registered

2023-07-04

Start date

2023-07-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthmatic patients

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients who fulfill the following (1) or (2) (1) Patients who are scheduled to receive a biological agent for asthma (2) Patients who are currently receiving a biologics for asthma and plan to change the formulation.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Number of exacerbations per year	—

Secondary

Measure	Time frame
ACQ6 ACT Forced expiratory volume in 1 second	—

Contacts

Public ContactNagai Tatsuya

Kameda Medical Center

nagai.tatsuya@kameda.jp+81-470922211

Outcome results